Basilea Pharmaceutica AG
Status: Publicly traded
Direct answer
Basilea Pharmaceutica AG is publicly traded on LSE under the ticker 0QNA.L.
Basilea Pharmaceutica AG is a revenue-generating biopharmaceutical company dedicated to developing innovative products to meet critical medical needs in both cancer treatment (oncology) and the fight against infections (anti-infectives). The company offers Cresemba, an antifungal medication available in both intravenous and oral forms, used to treat invasive aspergillosis and mucormycosis in the United States and...
Can you invest in Basilea Pharmaceutica AG?
Yes. Basilea Pharmaceutica AG trades publicly on LSE as 0QNA.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Basilea Pharmaceutica AG
Detailed equity research is provided by MarketSnap.